WisdomTree Issuer PLC : Net Asset Value(s)  

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
WisdomTree Issuer PLC : Net Asset Value(s)
  WisdomTree Issuer plc - Daily Fund Prices 01-November-16  
       
Fund Dealing Date ISIN Code Shares Base Net Assets NAV/Share
    in Issue Currency   
WisdomTree Emerging Asia Equity Income UCITS ETF 01/11/2016 IE00BYPGT035 900000 USD 8,924,685.85 9.9163
WisdomTree Emerging Markets Equity Income UCITS ETF 01/11/2016 IE00BQQ3Q067 2000000 USD 27,291,805.00 13.6459
WisdomTree Emerging Markets Small Cap Dividend UCITS ETF 01/11/2016 IE00BQZJBM26 500000 USD 7,543,195.48 15.0864
WisdomTree Enhanced Commodity UCITS ETF - USD 01/11/2016 IE00BZ1GHD37 125000 USD 1,272,806.68 10.1825
WisdomTree Enhanced Commodity UCITS ETF - USD Acc 01/11/2016 IE00BYMLZY74 1375000 USD 14,001,208.59 10.1827
WisdomTree Europe Equity Income UCITS ETF 01/11/2016 IE00BQZJBX31 2805000 EUR 32,541,225.85 11.6012
WisdomTree Europe Equity UCITS ETF - CHF Hedged Acc 01/11/2016 IE00BYQCZT11 71600 CHF 1,002,020.83 13.9947
WisdomTree Europe Equity UCITS ETF - EUR Acc 01/11/2016 IE00BYQCZX56 71000 EUR 999,129.92 14.0723
WisdomTree Europe Equity UCITS ETF - GBP Hedged 01/11/2016 IE00BYQCZQ89 70010 GBP 689,420.06 9.8475
WisdomTree Europe Equity UCITS ETF - USD Hedged 01/11/2016 IE00BVXBH163 4480000 USD 65,557,028.73 14.6333
WisdomTree Europe Equity UCITS ETF - USD Hedged Acc 01/11/2016 IE00BYQCZP72 70000 USD 1,108,450.84 15.835
WisdomTree Europe Small Cap Dividend UCITS ETF 01/11/2016 IE00BQZJC527 2890000 EUR 42,825,923.49 14.8187
WisdomTree Eurozone Quality Dividend Growth UCITS ETF - EUR Acc 01/11/2016 IE00BZ56TQ67 83000 EUR 1,077,765.78 12.9851
WisdomTree Germany Equity UCITS ETF - CHF Hedged Acc 01/11/2016 IE00BYQCZ914 72000 CHF 1,131,109.63 15.7099
WisdomTree Germany Equity UCITS ETF - EUR Acc 01/11/2016 IE00BYQCZC44 141000 EUR 1,950,457.37 13.833
WisdomTree Germany Equity UCITS ETF - GBP Hedged 01/11/2016 IE00BVXBGY20 2170000 GBP 19,442,799.29 8.9598
WisdomTree Germany Equity UCITS ETF - USD Hedged 01/11/2016 IE00BYQCZ682 70010 USD 1,083,756.98 15.48
WisdomTree Global Quality Dividend Growth UCITS ETF - USD Acc 01/11/2016 IE00BZ56SW52 125000 USD 2,004,612.71 16.0369
WisdomTree ISEQ 20 UCITS ETF 01/11/2016 IE00BVFB1H83 2300000 EUR 26,899,437.33 11.6954
WisdomTree Japan Equity UCITS ETF - CHF Hedged Acc 01/11/2016 IE00BYQCZL35 151250 CHF 2,345,761.16 15.5092
WisdomTree Japan Equity UCITS ETF - EUR Hedged Acc 01/11/2016 IE00BYQCZJ13 151000 EUR 1,996,508.03 13.2219
WisdomTree Japan Equity UCITS ETF - GBP Hedged 01/11/2016 IE00BYQCZF74 150010 GBP 1,359,706.23 9.0641
WisdomTree Japan Equity UCITS ETF - JPY Acc 01/11/2016 IE00BYQCZN58 601000 USD 10,011,560.42 16.6582
WisdomTree Japan Equity UCITS ETF - USD Hedged 01/11/2016 IE00BVXC4854 1650000 USD 21,791,174.46 13.2068
WisdomTree UK Equity Income UCITS ETF 01/11/2016 IE00BYPGTJ26 560000 GBP 3,022,036.66 5.3965
WisdomTree US Equity Income UCITS ETF - GBP Hedged Acc 01/11/2016 IE00BD6RZZ53 65000 GBP 843,751.70 12.9808
WisdomTree US Equity Income UCITS ETF 01/11/2016 IE00BQZJBQ63 2145000 USD 37,242,437.85 17.3624
WisdomTree US Quality Dividend Growth UCITS ETF - USD Acc 01/11/2016 IE00BZ56RG20 65000 USD 1,043,443.66 16.053
WisdomTree US Small Cap Dividend UCITS ETF 01/11/2016 IE00BQZJBT94 585000 USD 9,884,122.54 16.8959
Scroll down for more posts ▼

Top 10 Most Recent News Articles

WHO and RCSI Bahrain Join Forces on Health Initiatives

Updated Category News Views 454

Forging a Healthier Pathway In a world where healthcare challenges rise faster than my blood pressure during a stock market crash, the World Health Organization (WHO) and the Royal College of Surgeons in Ireland (RCSI) – Medical University of Bahrain have inked a deal to tackle these issues head-on. The memorandum of understanding (MoU) signed on November 15, 2026,...

Continue Reading
Kayla Harrison Dominates UFC 334, Earns Big Win

Updated Category News Views 59

Kicking off UFC 334 with a bang, Kayla Harrison didn't just step into the Octagon—she bulldozed her way through Amanda Nunes to retain her Women's Bantamweight Championship. This showdown didn't just electrify New York's Madison Square Garden, it shook the entire MMA landscape. Harrison, the face of Monster Energy's athlete roster, wasn't content with just defending her...

Continue Reading
JOYEE N01 Debuts Globally with First 2,000 Deliveries

Updated Category News Views 387

JOYYE N01 Breaks into the Global Market Now, here we go, folks—a Chinese car with ambitions bigger than the Sahara. On October 28, the JOYEE N01 rolled off the assembly line and into the international scene with a lot of fanfare at FAW's Yancheng Branch. Mark my words, this isn't just another model trying to strut into the global auto arena. This event delivered the...

Continue Reading
Berry Street Integrates AI with What Matters: Human Touch

Updated Category News Views 283

Health Meets AI at Berry Street In recent waves of news, Berry Street has decided to toss MyScribe, a standalone AI service, into its shopping cart and welcomed its brainwave behind it, Dr. Wasif Bokhari, into their corridors. Yep, they’ve snagged both the tech and the mind! It's the kind of move that makes you stop midway through your diner coffee. Here’s Berry...

Continue Reading
Innovent's Big Leap: Targeting European Lung Cancer Market

Updated Category News Views 162

Innovent's Regulatory Milestone in Europe They say every underdog has its day, and for Innovent Biologics, that time just might be now. Receiving a positive opinion from the Committee for Medicinal Products for Human Use (CHMP) is no small potatoes. Especially when we're talking lung cancer—a notorious heavyweight in the cancer world. The Finer Details of Zybrivo’s...

Continue Reading
InstaHeat 35K: FOGATTI Offers Upgraded RV Furnace Control

Updated Category News Views 493

Winter RV Trips Just Got Cozier There's nothing quite like hitting the open road in an RV during the winter months. But let's face it, nobody wants to return to a cabin that's as frigid as the great outdoors. Here's where FOGATTI steps up its game with the InstaHeat Ultra 35K RV Furnace. They’ve tinkered with the thermostat to iron out more precise control, just in time...

Continue Reading
Midea's R290 Tech: Real Green Cooling Revolution?

Updated Category News Views 66

A Fresh Breeze in Sustainable Cooling In the middle of Kigali’s innovation oasis, Midea RAC stood out at MOP38, the 38th Meeting of the Parties to the Montreal Protocol, flexing its sustainable tech muscles. We're talking about their R290 air conditioning technology—a natural refrigerant with zero ozone footprint and a global warming potential of a mere three. This is...

Continue Reading
Ampace Focuses on Battery Safety Standards at RE+ 2026

Updated Category News Views 77

Battery Safety Takes Center Stage No mystery here: the safety of our beloved lithium-ion batteries is crucial, especially as AI data centers sprout like weeds. At RE+ 2026, Ampace is putting its chips on the table by spotlighting this hot topic. Dr. Drew Feng, their Chief Safety Officer, is set to reveal the big guns: findings from the PU100 large-scale fire test. Mark...

Continue Reading
Novo's CagriSema Trials Show Promising Weight Loss

Updated Category News Views 421

Decoding CagriSema's Promise Let me tell you, when those corporate folks from Novo Nordisk announce something big like their investigational drug CagriSema at ObesityWeek® 2026, it’s time to take notice. This isn’t just your average press release about some new weight loss fad. We’re talking about a phase 3 REDEFINE 1 trial that opens up a treasure chest of data...

Continue Reading
Portillo's Faces Class Action: Investor Losses at Stake

Updated Category News Views 304

Investor Tensions Rise as Portillo's Inc. Lawsuit Unfolds Investment ain't all sunshine and rainbows, and if you've been holding Portillo's Inc. (NASDAQ: PTLO) stocks between September 19, 2023, and May 4, 2026, you might find yourself caught in a storm front. We're talking shareholder class action lawsuit, folks, thanks to some allegedly misguided management moves. This...

Continue Reading

Top 5 Most Recently Viewed Articles

Ventas to Showcase Investment Strategy at Real Estate Conference

Updated Category News Views 44

Ventas Engages Investors at Upcoming Conference Ventas, Inc. (NYSE: VTR) is gearing up to take part in significant investor meetings at the BofA Securities 2024 Global Real Estate Conference. This event presents a valuable chance for the company to connect with investors and share insights about its strategic direction and business model. Event Details and Participation...

Continue Reading
BioLineRx Explores Synergy in Ovarian Cancer Treatment

Updated Category News Views 151

New Hope on the Ovarian Cancer Front Every so often, something comes along and makes you stop and think—could this be the game-changer in the making? Well, what BioLineRx Ltd. (NASDAQ: BLRX) and Hemispherian AS just dropped at the ESMO 2026 feels a bit like that silver lining for folks fighting the uphill battle against homologous recombination (HR)-proficient ovarian...

Continue Reading
Analyst Ratings Show Confidence in Datadog and Others

Updated Category News Views 80

Recent Upgrades by Top Analysts Leading financial analysts from Wall Street have adjusted their outlooks on several prominent companies, reflecting a more optimistic market sentiment. Upgrades often signify increased confidence in a company's performance and present potential investment opportunities for savvy investors. Here, we delve into some of the standout upgrades...

Continue Reading
Unpacking the Increased Short Interest in Ventas (NYSE: VTR)

Updated Category News Views 77

Understanding Ventas's Short Interest Surge Ventas recently recorded an uptick in its short percent of float, which now stands at 25.59% since the last report. This notable development means that 9.80 million shares are currently sold short, translating to 3.19% of all regular shares available for trading. Given the trading volume, it would take traders approximately 3.33...

Continue Reading
Precigen's PAPZIMEOS: 7-Year Exclusivity & Long-Term Success

Updated Category News Views 54

Precigen's Game-Changer: PAPZIMEOS Secures Seven-Year Exclusivity Here's how you carve out a solid niche in the biotech world: deliver some killer results and snag yourself seven years in the driver’s seat. That's exactly what Precigen (NASDAQ: PGEN) has done with their PAPZIMEOS therapy, which got the stamp of approval from the FDA as the first exclusive treatment for...

Continue Reading